Passage Bio, Inc., in an organizational redesign to align resources with its R&D strategy and extend its cash runway, announced the departure of CFO Simona King and CTO Alex Fotopoulos around July 28, 2023. Kathleen Borthwick, the current VP of Finance, will serve as the Interim CFO from July 28, 2023. The company will decrease operating expenses by reducing the workforce by 26%, mainly in its CMC group, aiming to fund operations into Q4 2025.